References

No references inside the corpus for this window.

Cited by

• 2005External validity of randomised controlled trials: “To whom do the results of this trial apply?”2,541 cited
• 2006A simple and valid tool distinguished efficacy from effectiveness studies207 cited
• 2005Should Patients Have a Greater Role in Valuing Health States?187 cited
• 2005Sufficiently Important Difference: Expanding the Framework of Clinical Significance175 cited
• 2009Functional Neuroimaging of Reward Circuitry Responsivity to Monetary Gains and Losses in Posttraumatic Stress Disorder165 cited
• 1998Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis164 cited
• 2017Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund162 cited
• 2002Threats to the estimation of benefit: are preference elicitation methods accurate?141 cited
• 2002Risk Charts: Putting Cancer in Context117 cited
• 1999Toward a reconceptualization of communication cues to action in the health belief model: HIV test counseling101 cited
• 2015The Problematic Welfare Standards of Behavioral Paternalism90 cited
• 2000Unstable Preferences:86 cited
• 1997Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making.77 cited